Skip to content
Articles
Close Articles
Open Articles
Latest Articles
JCAD Archives
Acne & Rosacea
Aesthetic Dermatology
Cutaneous Oncology
Dermatologic Surgery
Device-Based Therapies
Eczema
Hair and Nails
Hidradenitis Suppurativa
Infectious Disease
Psoriasis
Pigmentation Disorders
Practice Management
Skin of Color
NP+PA Archives
JCAD.TV
Close JCAD.TV
Open JCAD.TV
Meeting Coverage
AAD Meeting Coverage 2025
Elevate Derm West Conference Coverage 2024
Masterclasses in Dermatology 2024
Science of Skincare Summit 2024
Maui Derm NP+PA Fall Coverage 2024
Expert Perspectives
Atopic Dermatitis
Vitiligo
Generalized Pustular Psoriasis
Skincare Science
Melanoma
Therapeutic Skincare
Targeted Phototherapy
Skin Barrier Care
Journal Review
Original Research Videos
Video Case Reports
Podcasts & Audio
JCAD Podcast
Psoriasis Advisor
Atopic Dermatitis Advisor
NP+PA
About
Close About
Open About
About JCAD
Author Guidelines
Permissions
Advertise
About JCAD
Author Guidelines
Permissions
Advertise
Contact Us
Subscribe
Share
Close Share
Open Share
Facebook
X-twitter
Linkedin
Blindness After Facial Injection
Prev
Previous Post
Management of Tyndall Effect
Next Post
Management of Ptosis
Next
Categories:
Acne
Rosacea
Atopic Dermatitis
Aesthetic Dermatology
Fillers
Botulinum Toxin
Chemical Peels
Cosmeceuticals and Skincare
Cosmetic Surgery
Aging Skin
Anti-aging
Microneedling
Cutaneous Oncology
Melanoma
Squamous Cell Carcinoma
Basal Cell Carcinoma
Mohs micrographic surgery
Actinic Keratosis
Lymphoma
Non-melanoma Skin Cancer
Photoaging
Sunburn and Sun Care
Primary Cutaneous Lymphomas
Dermatologic Surgery
Non-cosmetic surgery
Cosmetic Surgery
Mohs micrographic surgery
Device Based Therapies
Devices
Laser and Light Therapies
Photodynamic Therapy
Phototherapy
Ultrasound Therapy
Microneedling
Eczema
Atopic Dermatitis
Contact Dermatitis
Pruritus
Seborrheic Dermatitis
Hair and Nails
Hair and Nail Disorders
Alopecia
Onychomycosis
Hidradenitis Suppurativa
Infectious Disease
Infections
Molluscum Contagiosum
Onychomycosis
Verruca Vulgaris
Psoriasis
Pigmentation Disorders
Pigmentation Disorders
Melasma
Nevi
Vitiligo
Practice Management
Practice Management
Complications and Adverse Events
Skin of Color
Blindness After Facial Injection
Askari Townshend, MD
Share:
Recent Articles:
Hadas Skupsky, MD, FAAD: Pigmented Lesion Management for the Dermatologist
Read More
Letters to the Editor: May 2025
Read More
Tralokinumab as a Therapeutic Alternative for Dupilumab-associated Arthralgia in Atopic Dermatitis: A Multi-center Case Series
Read More
The Correlation between Hidradenitis Suppurativa and Irritable Bowel Diseases: A Systematic Review
Read More
A Clinician’s Guide to Dupilumab-related Ocular Surface Disease
Read More
A Review of Neoadjuvant PD-1 Inhibitors in the Setting of Cutaneous Malignancies
Read More
The Treatment of Pembrolizumab-induced Pruritus with Topical Roflumilast Cream 0.3% Once Daily
Read More
Ferulic Acid Use for Skin Applications: A Systematic Review
Read More
Safety Evaluation of Topical Products Containing Live Cultures and Ferment of Cutibacterium Acnes Subspecies Defendens Strain XYCM42 in Individuals Predisposed to Acne Vulgaris
Read More
Interpreting Safety Analyses in Psoriasis Clinical Trials
Read More
No posts found
1
2
3
…
164
Facebook
X-twitter
Linkedin
Categories:
Acne
Rosacea
Atopic Dermatitis
Aesthetic Dermatology
Fillers
Botulinum Toxin
Chemical Peels
Cosmeceuticals and Skincare
Cosmetic Surgery
Aging Skin
Anti-aging
Microneedling
Cutaneous Oncology
Melanoma
Squamous Cell Carcinoma
Basal Cell Carcinoma
Mohs micrographic surgery
Actinic Keratosis
Lymphoma
Non-melanoma Skin Cancer
Photoaging
Sunburn and Sun Care
Primary Cutaneous Lymphomas
Dermatologic Surgery
Non-cosmetic surgery
Cosmetic Surgery
Mohs micrographic surgery
Device Based Therapies
Devices
Laser and Light Therapies
Photodynamic Therapy
Phototherapy
Ultrasound Therapy
Microneedling
Eczema
Atopic Dermatitis
Contact Dermatitis
Pruritus
Seborrheic Dermatitis
Hair and Nails
Hair and Nail Disorders
Alopecia
Onychomycosis
Hidradenitis Suppurativa
Infectious Disease
Infections
Molluscum Contagiosum
Onychomycosis
Verruca Vulgaris
Psoriasis
Pigmentation Disorders
Pigmentation Disorders
Melasma
Nevi
Vitiligo
Practice Management
Practice Management
Complications and Adverse Events
Skin of Color
Recent Articles:
James Del Rosso, DO, and Christopher Bunick, MD: Tralokinumab as a Therapeutic Alternative for Dupilumab-associated Arthralgia in Atopic Dermatitis—A Multi-center Case Series
Read More
Michael Cameron, MD, FAAD, and Christopher Bunick, MD, PhD: The Future of Personalized Atopic Dermatitis Treatments to Predict and Avoid Adverse Events
Read More
Naiem Issa, MD, PhD, and Christopher Bunick, MD, PhD: Mechanisms of Dupilumab-associated Arthralgia in Patients with Atopic Dermatitis
Read More
Hadas Skupsky, MD, FAAD: Pigmented Lesion Management for the Dermatologist
Read More
Jennifer Silva, APRN-DNP: Safety Considerations for Treating Patients with Vitiligo
Read More
Letters to the Editor: May 2025
Read More
Tralokinumab as a Therapeutic Alternative for Dupilumab-associated Arthralgia in Atopic Dermatitis: A Multi-center Case Series
Read More
The Correlation between Hidradenitis Suppurativa and Irritable Bowel Diseases: A Systematic Review
Read More
A Clinician’s Guide to Dupilumab-related Ocular Surface Disease
Read More
A Review of Neoadjuvant PD-1 Inhibitors in the Setting of Cutaneous Malignancies
Read More
No posts found
1
2
3
…
202
Tags:
Prev
Previous
Management of Tyndall Effect
Next
Management of Ptosis
Next
